PDF(Pubmed)
Abstract：
UNASSIGNED: The goal of this activity is to educate pharmacists about the use of idarucizumab for the reversal of dabigatran anticoagulant activity.
UNASSIGNED: At the completion of this activity, the reader will be able to:1.Describe the pharmacology and pharmacokinetics of idarucizumab.2.Discuss the risks associated with the use of idarucizumab.3.Discuss the potential benefit of idarucizumab for an individual patient.4.Apply the information on the use of idarucizumab to a case study.
UNASSIGNED: At the completion of this activity, the reader will be able to:1.Describe the pharmacology and pharmacokinetics of idarucizumab.2.Discuss the risks associated with the use of idarucizumab.3.Discuss the potential benefit of idarucizumab for an individual patient.4.Apply the information on the use of idarucizumab to a case study.
摘要：
■这项活动的目的是教育药剂师关于使用idarucizumab逆转达比加群抗凝血活性。
■在此活动完成时，读者将能够：1。描述idarucizumab的药理学和药代动力学。讨论与使用idarucizumab相关的风险3。讨论idarucizumab对个体患者的潜在益处。将有关idarucizumab使用的信息应用于案例研究。
■在此活动完成时，读者将能够：1。描述idarucizumab的药理学和药代动力学。讨论与使用idarucizumab相关的风险3。讨论idarucizumab对个体患者的潜在益处。将有关idarucizumab使用的信息应用于案例研究。
